Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP).

[1]  D. Frappaz,et al.  The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease: A prospective study of 42 patients‐‐Results of the NBL 90 study of the French Society of Pediatric Oncology , 1996, Cancer.

[2]  A. Donfrancesco,et al.  Localized resectable neuroblastoma: results of the second study of the Italian Cooperative Group for Neuroblastoma. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Look,et al.  Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study. , 1995, Cancer research.

[4]  A. Donfrancesco,et al.  Localized but unresectable neuroblastoma: treatment and outcome of 145 cases. Italian Cooperative Group for Neuroblastoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  F. Berthold,et al.  Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. , 1993, Progress in clinical and biological research.

[6]  D. Frappaz,et al.  Etoposide and carboplatin in neuroblastoma: a French Society of Pediatric Oncology phase II study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  A. Nakagawara,et al.  Neuroblastoma: Effect of genetic factors on prognosis and treatment , 1992, Cancer.

[8]  M. Kaneko,et al.  Therapeutic significance of surgery in advanced neuroblastoma: a report from the study group of Japan. , 1992, Journal of pediatric surgery.

[9]  J. Shuster,et al.  A population-based study of neuroblastoma incidence, survival, and mortality in North America. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  J. Shuster,et al.  Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  H. Sather,et al.  A comparison of four staging systems for localized and regional neuroblastoma: a report from the Childrens Cancer Study Group. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  H. Sather,et al.  Improvement in survival after excision of primary tumor in stage III neuroblastoma. , 1989, Journal of pediatric surgery.

[13]  K. Matthay,et al.  Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  H. Sather,et al.  Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. , 1985, The New England journal of medicine.

[15]  J. Bernard,et al.  Evaluation of the role of surgery in 130 patients with neuroblastoma. , 1985, Journal of pediatric surgery.

[16]  S. Sallan,et al.  Improved survival in neuroblastoma using multimodality therapy. , 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  S. Sallan,et al.  Neuroblastoma: the Joint Center for Radiation Therapy/Dana-Farber Cancer Institute/Children's Hospital experience. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  C. Koop,et al.  The role of multimodal therapy in patients with local and regional neuroblastoma. , 1984, Journal of pediatric surgery.

[19]  J. Mann,et al.  Stage II neuroblastoma. Adverse prognostic significance of lymph node involvement. , 1982, Archives of disease in childhood.

[20]  V. Castel,et al.  Treatment of stage III neuroblastoma with emphasis on intensive induction chemotherapy: a report from the Neuroblastoma Group of the Spanish Society of Pediatric Oncology. , 1995, Medical and pediatric oncology.

[21]  B. Korf,et al.  Stage III neuroblastoma over 1 year of age at diagnosis: improved survival with intensive multimodality therapy including multiple alkylating agents. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  J. Grosfeld,et al.  Stage II neuroblastoma--does adjuvant irradiation contribute to cure? , 1985, Medical and pediatric oncology.

[23]  S. Sallan,et al.  Influence of local-regional lymph node metastases on prognosis in neuroblastoma. , 1984, Medical and pediatric oncology.